R. Jay Luly

Affiliations

  • President And Ceo at Enanta Pharmaceuticals Inc (ENTA), 2024-02-15
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ENTA $9.63 7,230 Officer, Director 806,793 2023-12-05 Filing
ENTA $46.13 1,566 Officer, Director 819,810 2023-03-13 Filing
ENTA $45.31 15,649 Officer, Director 821,376 2023-03-13 Filing
ENTA $44.81 10,697 Officer, Director 837,025 2023-03-13 Filing
ENTA $45.49 13,603 Officer, Director 773,805 2022-12-16 Filing